Asia Pacific: The conjunctivitis market in Asia Pacific is projected to experience rapid growth, particularly in countries like China, Japan, and South Korea. The increasing geriatric population, changing lifestyle habits, and rising healthcare expenditures are some of the key factors contributing to market expansion in this region. Moreover, the government initiatives to improve eye care services are further boosting market growth.
Europe: In Europe, countries like the United Kingdom, Germany, and France are witnessing a steady growth in the conjunctivitis market. The rising prevalence of eye infections, allergies, and other ocular diseases is driving the demand for effective treatment options in the region. Additionally, the presence of major market players and advancements in healthcare infrastructure are supporting market growth in Europe.